The new global CoLaborator concept is aimed at providing young companies in the area of chemistry and biosciences ready-to-use laboratory and office infrastructure in the immediate vicinity of the company’s own research facilities.
Berlin’s Governing Mayor Klaus Wowereit said the new CoLaborator shall promote the exchange of knowledge and expertise among top international researchers in the city and help startup companies put their ideas into practice.
"With globally recognized universities and research institutions, technology parks, the Bayer research center, and an inspiring startup scene, the Berlin region is one of the most important scientific regions in Europe," Wowereit said.
The newly CoLaborator allows young life sciences companies to rent equipped research laboratories and office space in a separate building with about 800m² of floor space and around 420m² space for laboratories.
The new ‘CoLaborator’ is located at the company’s R&D Center at Müllerstrasse 178, 13353 Berlin.
Bayer HealthCare member of the Executive Committee and head of Global Drug Discovery Andreas Busch said the company wants to enable young entrepreneurs to realize their innovative ideas.
"With the CoLaborator we are creating an environment where young companies find ideal conditions for this purpose," Busch said.
"In addition, we are encouraging scientific exchange and want to create a stimulating environment for research and innovation. The establishment of the CoLaborator is a logical step in enhancing our partnership models in research and thus an important element of our innovation strategy."
The company said that its first tenants, Calico, DexLeChem and provitro, have already moved into the new CoLaborator premises in Berlin.